Several possibilities in treating advanced gastric cancer exist. Radical surgery associated with chemotherapy represents the cornerstone. Which one is more effective among neoadjuvant, adjuvant or perioperative chemotherapy is still a matter of debate. Several innovative results showed the necessity to keep increasingly into consideration the intraperitoneal administration of chemotherapies. Moreover, classical drugs and their ways of administration should be combined with the new ones to improve results. Lastly the prevention of recurrence should be considered: one possibility is to administer intraperitoneal chemotherapy earlier in the therapeutic algorithm. (www.actabiomedica.it).

Advanced gastric cancer: The value of systemic and intraperitoneal chemotherapy

Ansaloni L.;
2018-01-01

Abstract

Several possibilities in treating advanced gastric cancer exist. Radical surgery associated with chemotherapy represents the cornerstone. Which one is more effective among neoadjuvant, adjuvant or perioperative chemotherapy is still a matter of debate. Several innovative results showed the necessity to keep increasingly into consideration the intraperitoneal administration of chemotherapies. Moreover, classical drugs and their ways of administration should be combined with the new ones to improve results. Lastly the prevention of recurrence should be considered: one possibility is to administer intraperitoneal chemotherapy earlier in the therapeutic algorithm. (www.actabiomedica.it).
2018
Esperti anonimi
Inglese
Internazionale
STAMPA
89
8-S
104
109
6
Advanced gastric cancer; Carcinosis; Chemotherapy; Hipec; Intraperitoneal; Metastasis; Surgery; Adenocarcinoma; Angiogenesis Inhibitors; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cytoreduction Surgical Procedures; Gastrectomy; Humans; Infusions, Parenteral; Meta-Analysis as Topic; Minimally Invasive Surgical Procedures; Molecular Targeted Therapy; Neoadjuvant Therapy; Neoplasm Staging; Peritoneal Neoplasms; Protein Kinase Inhibitors; Stomach Neoplasms
no
11
info:eu-repo/semantics/article
262
Coccolini, F.; Fugazzola, P.; Ansaloni, L.; Sartelli, M.; Cicuttin, E.; Leandro, G.; De'Angelis, G. L.; Gaiani, F.; Di Mario, F.; Tomasoni, M.; Catena...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
none
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1348203
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 12
  • ???jsp.display-item.citation.isi??? ND
social impact